Clinical Trial Update: Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma [Phase 2]

View source ↗

Summary

Completed Phase 2 study evaluating weekly carfilzomib with melphalan and prednisone in untreated elderly patients with symptomatic multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (Kyprolis) (carfilzomib)
• Melphalan (Melphalan)
• PREDNISONE (Prednisone)

Snippet

Sponsor: University Hospital, Lille | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED